Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00207350 · ClinicalTrials.gov registry record · NA

Neurosurgical Use of Interstitial Laser Therapy (ILT)

A NA study of Brain Tumor, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT00207350 is a NA study of Brain Tumor that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6 participants, below the 282-participant average among 69 other Brain Tumor trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00207350, a NA study of Brain Tumor, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The researchers' specific aims are to test the following hypotheses: Hypothesis 1: A tumor can be completely ablated by ILT with MRI-guidance. Hypothesis 2: The MRI-based 3D temperature map of tissue during ILT is predictive of destruction. Hypothesis 3: The 3D "thermal dose" map that is based on the tissue's temperature over time is more predictive of tissue destruction than the temperature map.

Conditions Studied

Interventions

  • DEVICE Interstitial Laser Therapy

Study Locations (1)

Massachusetts

  • Brigham & Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2002-01
Est. Completion 2006-12
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT00207350

The ClinicalTrials.gov registry entry for NCT00207350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 282-participant average among 69 other Brain Tumor trials with a reported enrollment target (98% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Interstitial Laser Therapy is the first listed.

NCT00207350 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00207350 about?

NCT00207350 is a clinical study titled "Neurosurgical Use of Interstitial Laser Therapy (ILT)". The researchers' specific aims are to test the following hypotheses: Hypothesis 1: A tumor can be completely ablated by ILT with MRI-guidance. Hypothesis 2: The MRI-based 3D temperature map of tissue during ILT is predictive of destruction. Hypothesis 3: The 3D "thermal dose" map that is based on...

What is the current status of trial NCT00207350?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2002-01. Estimated completion is 2006-12.

What conditions does trial NCT00207350 study?

This clinical trial studies the following conditions: Brain Tumor.

What interventions are being tested in trial NCT00207350?

The interventions under investigation include: Interstitial Laser Therapy (DEVICE).

Who is sponsoring clinical trial NCT00207350?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00207350 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.